Valve-in-Valve Transcatheter Aortic Valve Implantation With Acurate neo for a Degenerated bio-Bentall

Alessandra Laricchia, Antonio Mangieri, Francesco Gallo, Azeem Latib, Andrea Fisicaro, Rita Conti, Angelo Squeri, Lorenzo Mantovani, Antonio Colombo, Francesco Giannini

Research output: Contribution to journalArticlepeer-review


A 79-year-old man with heart failure was referred to our attention for a degenerated bio-Bentall Mitroflow 27. The Heart Team decided for a valve-in-valve (ViV) transcatheter aortic valve implantation with an Acurate neo M associated to coronary protection due to high risk of coronary obstruction (CO). Besides the supra-anular design, this case shows additional potential advantages of the Acurate neo in ViV procedures: the upper crown, which is meant to favor supra-anular anchoring, also let to cap the bioprosthesis leaflets and minimize the risk of CO; there is not any interference between the valve cage and the stents protruding into the aorta, avoiding potential stent crushing and assuming an easier future coronary engagement.

Original languageEnglish (US)
Pages (from-to)18-20
Number of pages3
JournalCardiovascular Revascularization Medicine
Issue number11
StatePublished - Nov 2020


  • Coronary obstruction
  • Coronary protection
  • Transcatheter aortic valve implantation
  • Valve-in-valve

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Valve-in-Valve Transcatheter Aortic Valve Implantation With Acurate neo for a Degenerated bio-Bentall'. Together they form a unique fingerprint.

Cite this